Table 2.
No. days in case/control periods | Refill of the same drug, strength and dosage form from the same manufacturerb | Switch between the same drug, strength and dosage form but from different manufacturersc | Refill-adjusted odds ratio for switching | ||
---|---|---|---|---|---|
nd | Odds ratio (95% CI) | nd | Odds ratio (95% CI) | Odds ratio (95% CI) | |
21 | 116 | 2.31 (1.56–3.44) | 15 | 2.75 (0.88–8.64) | 1.19 (0.35–3.99) |
28 | 151 | 2.08 (1.48–2.93) | 19 | 2.17 (0.82–5.70) | 1.04 (0.37–2.90) |
In case-crossover studies, odds ratios are inherently adjusted for time-invariant patient factors
Includes refilling of brand products and refilling of generic products
included switching between brand and generic products, generic and brand products, and two generic products from different manufacturers
n represents the number of index events that contributed to the estimation of the odds ratio